Flumazenil → HCID 20434818, compound
Reaction equation
[F:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]3[CH:12]=[N:13][C:14]([C:15]([O:17][CH2:18][CH3:19])=[O:16])=[C:10]3[CH2:9][N:8]([CH3:20])[C:7](=[O:21])[C:6]=2[CH:22]=1.O[CH2:24][CH:25]1CC1>CCO.CCO.CCO.CCO.[Ti].[F-].[K+]>[F:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]3[CH:12]=[N:13][C:14]([C:15]([O:17][CH2:18][CH:19]4[CH2:25][CH2:24]4)=[O:16])=[C:10]3[CH2:9][N:8]([CH3:20])[C:7](=[O:21])[C:6]=2[CH:22]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
A mixture of 5 g (16.5 mmol) of ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate, 1.8 g (8 mmol) of tetraethyl orthotitanate and 16.5 g (230 mmol) of hydroxymethyl-cyclopropane is stirred at 110° overnight, evaporated to dryness, the residue is taken up in methylene chloride and the solution obtained is stirred for 0.5 hour with 50 ml of a saturated potassium fluoride solution. The emulsion obtained is filtered through siliceous earth, the separated organic phase is washed with water, dried over magnesium sulphate and evaporated. By crystallization from ethyl acetate there is obtained cyclopropylmethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate of melting point 156-157°.
Workup
- customevaporated to dryness
- customthe solution obtained
- customThe emulsion obtained
- filtrationis filtered through siliceous earth
- washthe separated organic phase is washed with water
- dry with materialdried over magnesium sulphate
- customevaporated
- customBy crystallization from ethyl acetate
Sources & evidence
- ORD record
- ord-668efbf55c8b4a9d99a36944498bb161
- Source dataset
- uspto-grants-1984_12
- Patent number
- US04489003
Reaction notes
Loading…